Injectable/IV NAD+ is not FDA-approved (or approved by any major regulator) for energy, metabolic or longevity uses, and its safety and efficacy for these uses are not established presented for research and educational use only
Most cosmetic formulas sit in the 0.11% range and deliver results when used consistently
For injury recovery, track pain levels (0 to 10 scale), range of motion, and functional capacity
10.1016/j.fct.2023.114090 94 WdowiakA.BakalczukS.FilipM.LaganaA
Anal Biochem 126(1):131138 Heltberg ML, Awada HN, Lucchetti A, Jensen MH, Dreyer JK, Rasmussen RN (2022) Biophysical modeling of dopaminergic denervation landscapes in the striatum reveals new therapeutic strategy
Concentrations and routes referenced below are drawn from peer-reviewed preclinical literature on each peptide individually